Business
GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.
HAMBURG, Germany & MUNICH, March 05, 2026--GAIA and Daiichi Sankyo Europe Enter Exclusive Partnership to Launch Next-Generation Digital Therapeutic for Cardiovascular Care in Europe.
About this update from Daiichi Sankyo Company, Limited
[{"type":"image","alt":"Dr. Mario Weiss, Founder & CEO of GAIA AG","displaySize":"","headline":null,"caption":"Dr. Mario Weiss, Founder & CEO of GAIA AG","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":270,"url":"https://media.zenfs.com/en/business-wire.com/08ef335d23a37efe4cfbec717b52cf19"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/nk67MLgucEyUqXeRvrpxIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/08ef335d23a37efe4cfbec717b52cf19","width":480,"height":270}},"lazy":false},{"type":"image","alt":"Oliver Appelhans, Head of Specialty Business at Daiichi Sankyo Europe GmbH","displaySize":"","headline":null,"caption":"Oliver Appelhans, Head of Specialty Business at Daiichi Sankyo Europe GmbH","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":270,"url":"https://media.zenfs.com/en/business-wire.com/ff337fefc12159b2c4554080f4b15334"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/My26tgYCnrkl_77FGToYxQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTU0MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/ff337fefc12159b2c4554080f4b15334","width":480,"height":270}}},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":5680,"height":1749,"url":"https://media.zenfs.com/en/business-wire.com/ab137ffb6eeb470dad1efd11473c5cf4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/gIEu0Uo1hazWAucErqOzUg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTI5NjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/ab137ffb6eeb470dad1efd11473c5cf4","width":960,"height":296},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/C.4sx0d34jYc1WUGbQXjZA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTI0MDA7aD03NDA7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/ab137ffb6eeb470dad1efd11473c5cf4","width":1200,"height":370}}},{"type":"text","content":"HAMBURG, Germany & MUNICH, March 05, 2026--(BUSINESS WIRE)--GAIA, the pioneer in evidence-based digital therapeutics and Daiichi Sankyo Europe, today announced an exclusive strategic partnership to commercialize lipodia upon regulatory approval1.","length":250,"tagName":"p"},{"type":"text","content":"This digital therapeutic is designed to support adults living with hypercholesterolemia. The compre...